Actively Recruiting

Phase Not Applicable
Age: 18Years - 45Years
All Genders
NCT06262529

Neurocognitive Impairment After Ischemic Stroke

Led by Centre Hospitalier Universitaire de Nice · Updated on 2025-03-20

16

Participants Needed

2

Research Sites

169 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Affecting more than 150,000 patients in France, stroke is a major public health issue and a leading cause of disability worldwide. In western countries, 80-85% of strokes are of ischemic subtype. This study will focus on young adults, aged 18-45, with a diagnosis of ischemic stroke. Studies assessing post-stroke cognition in young patients reported an alarming prevalence of cognitive impairment, affecting about 60% of stroke survivors between 4 and 12 months after the acute event. However, longitudinal data on neurocognitive trajectories (i.e., the evolution of cognitive impairment over time) in young patients with ischemic stroke are lacking. Collecting such data requires an exhaustive neuropsychological assessment and several functional evaluations, at different times, for the same patient. Repeated neurocognitive study of young patients with ischemic stroke will enable: a description of the prevalence of impaired global cognitive efficiency, an analysis of the specific neurocognitive domains affected, and the tracing of trajectories of recovery from cognitive impairment over time, in terms of global cognitive efficiency and as a function of specific neurocognitive domains (memory, executive, attentional, social cognition, instrumental functions, fatigability, etc.). Up to date, the clinic-radiological predictors and associated factors of neurocognitive impairment after ischemic stroke in young patients have not been studied. Ischemic stroke causes acute brain lesions of the gray matter (GM) and white matter (WM). Numerous studies suggest that cognitive health may be more closely linked to the integrity of WM than to GM. Magnetic resonance imaging (MRI), and in particular diffusion tensor imaging (DTI) sequences, analyze WM bundles. By using fiber tracking algorithms image analysis enable the WM fiber bundle reconstruction and allow quantifying the volume of lesions (pre-existing and ischemic stroke-induced) in the WM tract. The aim of this study is to study whether the extension of pre-existing and acute white matter lesions is associated with poorer cognitive recovery after ischemic stroke, both in terms of global cognitive performance and impairment in specific neurocognitive domains.

CONDITIONS

Official Title

Neurocognitive Impairment After Ischemic Stroke

Who Can Participate

Age: 18Years - 45Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Age between 18 and 45 years
  • Diagnosed with ischemic stroke confirmed by brain MRI
  • Ability to understand and complete study tests and questionnaires in French
  • Affiliated with a social security scheme
  • Signed informed consent form
Not Eligible

You will not qualify if you...

  • Pre-existing cognitive impairment or clinical dementia
  • Severe functional dependence before stroke (Modified Rankin Scale score 5)
  • Any neurological or psychiatric comorbidity
  • Visual impairment, blindness, or deafness
  • Severe speech or language disorders interfering with neuropsychological testing
  • Severe motor disorders preventing the use of dominant upper limb for written tests
  • Contraindication to MRI
  • Pregnancy
  • HIV-positive status
  • Withdrawal of informed consent
  • Use of alcohol or narcotics on the day of neuropsychological assessments

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

cannes Hospital

Cannes, France, 06600

Not Yet Recruiting

2

Nice University Hospital

Nice, France, 06000

Actively Recruiting

Loading map...

Research Team

M

Marina PASSALBONI

CONTACT

B

Barbara CASOLLA

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

OTHER

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here